首页> 外国专利> Antigen-specific T cell inducer, antibody production inducer, immune enhancer, and vaccine

Antigen-specific T cell inducer, antibody production inducer, immune enhancer, and vaccine

机译:抗原特异性T细胞诱导剂,抗体产生诱导剂,免疫增强剂和疫苗

摘要

A novel antigen-specific T cell inducer, a novel antibody production inducer, a novel immune enhancer, and a novel vaccine, and a novel antigen-specific T cell induction method, antibody production induction method, a novel immune enhancement method, and a novel tumor treatment Methods and novel pathogen treatment methods are provided. A complete adjuvant prepared by inactivating herpes simplex virus (HSV) and adding it to an incomplete adjuvant is used as an antigen-specific T cell inducer, antibody production inducer, or immune enhancer, These antigen-specific T cell inducers, antibody production inducers, or immunopotentiators are used in combination with antigens to form vaccines. At that time, by using a cancer-specific antigen or a pathogen-specific antigen as an antigen, a tumor treatment method and a pathogen infection treatment method are obtained.
机译:新型抗原特异性T细胞诱导剂,新型抗体产生诱导剂,新型免疫增强剂和新型疫苗,以及新型抗原特异性T细胞诱导方法,抗体产生诱导方法,新型免疫增强方法和新型提供了肿瘤治疗方法和新颖的病原体治疗方法。通过灭活单纯疱疹病毒(HSV)并将其添加到不完全佐剂中制备的完整佐剂可用作抗原特异性T细胞诱导剂,抗体产生诱导剂或免疫增强剂。这些抗原特异性T细胞诱导剂,抗体产生诱导剂,免疫增强剂或免疫增强剂与抗原结合使用可形成疫苗。那时,通过使用癌症特异性抗原或病原体特异性抗原作为抗原,获得了肿瘤治疗方法和病原体感染治疗方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号